Table 1.
Societal approaches |
Reducing restrictions on lawful access to prescription opioids, because such restrictions may be driving some people toward the illegal market |
Treatment for the millions who have opioid-use disorder |
Removal of impediments to full coverage of medications approved by the US Food and Drug Administration for treatment of opioid-use disorder |
Partnerships between public and private payers, including insurance companies, to develop reimbursement models that support evidence-based and cost-effective comprehensive pain management, including drug and nondrug treatments for pain |
Pharmacological approaches |
Access to methadone and buprenorphine (substitute µ-opioid agonists) in a structured withdrawal program |
Access to naloxone (a µ-opioid antagonist prescribed to rescue people dying as a result of respiratory depression from an opioid) |
Approaches to address the opioid epidemic are from Refs. 50 and 65.